DRG 838

Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach

Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach

Introduction of High-dose Interleukin-2 into Central Vein, Open Approach

Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach

Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach

Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach

Introduction of High-dose Interleukin-2 into Central Artery, Open Approach

Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach

Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach

Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach

Acute lymphoblastic leukemia not having achieved remission

Acute lymphoblastic leukemia, in remission

Acute lymphoblastic leukemia, in relapse

Acute myeloblastic leukemia, not having achieved remission

Acute myeloblastic leukemia, in remission

Acute myeloblastic leukemia, in relapse

Acute promyelocytic leukemia, not having achieved remission

Acute promyelocytic leukemia, in remission

Acute promyelocytic leukemia, in relapse

Acute myelomonocytic leukemia, not having achieved remission

Acute myelomonocytic leukemia, in remission

Acute myelomonocytic leukemia, in relapse

Acute myeloid leukemia with 11q23-abnormality not having achieved remission

Acute myeloid leukemia with 11q23-abnormality in remission

Acute myeloid leukemia with 11q23-abnormality in relapse

Acute myeloid leukemia with multilineage dysplasia, not having achieved remission

Acute myeloid leukemia with multilineage dysplasia, in remission

Acute myeloid leukemia with multilineage dysplasia, in relapse

Acute monoblastic/monocytic leukemia, not having achieved remission

Acute monoblastic/monocytic leukemia, in remission

Acute monoblastic/monocytic leukemia, in relapse

Acute erythroid leukemia, not having achieved remission

Acute erythroid leukemia, in remission

Acute erythroid leukemia, in relapse

Acute megakaryoblastic leukemia not having achieved remission

Acute megakaryoblastic leukemia, in remission

Acute megakaryoblastic leukemia, in relapse

Acute panmyelosis with myelofibrosis not having achieved remission

Acute panmyelosis with myelofibrosis, in remission

Acute panmyelosis with myelofibrosis, in relapse

Acute leukemia of unspecified cell type not having achieved remission

Acute leukemia of unspecified cell type, in remission

Acute leukemia of unspecified cell type, in relapse

Encounter for follow-up examination after completed treatment for malignant neoplasm

Encounter for antineoplastic chemotherapy

Encounter for antineoplastic immunotherapy